[XENE] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
09-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -28.24%
YoY- -32.93%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 6,554 13,384 7,078 3,329 3,500 0 0 -
PBT -9,058 -214 -7,485 -11,412 -8,866 -10,036 -11,304 -13.69%
Tax -203 -39 -1 -36 5 -29 37 -
NP -8,855 -175 -7,484 -11,376 -8,871 -10,007 -11,341 -15.16%
Tax Rate - - - - - - - -
Total Cost 15,409 13,559 14,562 14,705 12,371 10,007 11,341 22.60%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -135.11 -1.31 -105.74 -341.72 -253.46 0.00 0.00 -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -0.25 -0.01 -0.23 -0.34 -0.34 -0.39 -0.44 -31.32%
EPS Diluted -0.25 -0.01 -0.23 -0.34 -0.34 -0.39 -0.44 -31.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.